Home  >  News
Eppendorf_eBook_Centrifuge_May25
you can get e-magazine links on WhatsApp. Click here
News
  Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million,   May 21, 2025
  AstraZeneca completes acquisition of biotech company, EsoBiotec,   May 21, 2025
  Chugai files regulatory application with Japanese MHLW for additional indication of Tecentriq to treat thymic carcinoma,   May 20, 2025
  Pfizer enters exclusive global, ex-China licensing pact with 3SBio for development, manufacturing & commercialization of SSGJ-707,   May 20, 2025
  GSK’s Blenrep combinations receives Japanese approval for treatment of relapsed/refractory multiple myeloma,   May 20, 2025
  Taiwan FDA approves Chugai Pharma’s PiaSky for subcutaneous treatment of patients with paroxysmal nocturnal hemoglobinuria,   May 20, 2025
  Bristol Myers Squibb gets European nod for perioperative regimen of neoadjuvant Opdivo and chemotherapy followed by adjuvant Opdivo for resectable, high-risk NSCLC with PD-L1 expression =1%,   May 19, 2025
  UK MHRA approves Janssen-Cilag’s guselkumab for Crohn’s disease and ulcerative colitis,   May 19, 2025
  BioMarin enters agreement to acquire Inozyme Pharma for $270 million,   May 19, 2025
  Merck’s Welireg receives US FDA approval to treat locally advanced, unresectable or metastatic pheochromocytoma or paraganglioma,   May 16, 2025
  US FDA begins action to remove ingestible fluoride prescription drug products for children from the market,   May 15, 2025
  Japanese MHLW approves Chugai’s Elevidys as a gene therapy product to treat Duchenne muscular dystrophy,   May 15, 2025
  US FDA accepts and grants priority review status to Regenxbio’s BLA for clemidsogene lanparvovec to treat Mucopolysaccharidosis II,   May 15, 2025
  Chugai Pharma seeks Japanese additional indication approval for Tecentriq to treat thymic carcinoma,   May 15, 2025
  GSK to buy Boston Pharma’s efimosfermin, a phase III-ready potential best-in-class specialty medicine to treat and prevent progression of SLD,   May 15, 2025
  HHS, US FDA issue RFI on deregulatory plan to lower costs and empower providers,   May 15, 2025
  Recipharm, ProductLife Group announce strategic partnership to speed up development projects,   May 14, 2025
  Barentz to strengthen its pharmaceuticals market presence in Asia Pacific through the envisaged acquisition of Fengli in China,   May 14, 2025
  Trump signs landmark executive order slashing prescription drug prices between 50% & 90%,   May 13, 2025
  AstraZeneca’s Trixeo Aerosphere approved in UK as first inhaled respiratory medicine using next-generation propellant with near-zero GWP,   May 13, 2025

  • Results Found: 21812
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 1091
 Back
 
Avians_2025
API_China_2025
CPHISEA25
worldadc-asia_25
ProPak_Asia_2025
CPHI_PMEC_China_2025
Pharmatech_Lab_Expo2025
CPHI_Hi_Korea_2025
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram